Spiros Manolatos

Spiros Manolatos has extensive experience in clinical research, primarily in the biopharmaceutical and biotechnology sectors. Currently serving as CRA II at Parexel since January 2022, Spiros specializes in ophthalmology, focusing on eye oncology, diabetic retinopathy, gene therapy, and nAMD. Previously, as a CRA I, Spiros worked in dermatology, immunology, and ophthalmology. Spiros held the position of Clinical Research Coordinator at Stony Brook Medicine from October 2020 to January 2022, managing multiple therapeutic areas for the Research Foundation of SUNY. Prior experience at NYU Langone Health as a Clinical Research Coordinator involved managing industry-sponsored clinical trials in neurology and tasks related to fresh brain tissue collection. Additional roles include Scientific Consultant at Americord Registry and Stem Cell Scientist at Interbiobank Ltd. Educational qualifications include an MSc in Biotechnology from the University of Bedfordshire and a Bachelor's degree in Biological Sciences from Hunter College.